# EDGAR Filing Document

**Accession Number:** 0001921783
**File Stem:** 0001104659-25-065775
**Filing Date:** 2025-7
**Character Count:** 8752
**Document Hash:** 8389d8b5039f6644c30d78da716699f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-065775.hdr.sgml**: 20250703

**ACCESSION NUMBER**: 0001104659-25-065775

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250702

**FILED AS OF DATE**: 20250703

**DATE AS OF CHANGE**: 20250703

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** RedCo II Master Fund, L.P.
- **CENTRAL INDEX KEY:** 0001921783

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36076
- **FILM NUMBER:** 251105527

**BUSINESS ADDRESS:**
- **STREET 1:** C/O MAPLES CORPORATE SERVICES LIMITED
- **STREET 2:** PO BOX 309, UGLAND HOUSE
- **CITY:** GEORGE TOWN, GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 4154899980

**MAIL ADDRESS:**
- **STREET 1:** ONE LETTERMAN DRIVE, BLDG D, STE D3-300
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94129
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FATE THERAPEUTICS INC
- **CENTRAL INDEX KEY:** 0001434316
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 651311552
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 12278 SCRIPPS SUMMIT DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131
- **BUSINESS PHONE:** 858.875.1803

**MAIL ADDRESS:**
- **STREET 1:** 12278 SCRIPPS SUMMIT DRIVE
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92131

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>RedCo II Master Fund, L.P.<br><sub>(Last) (First) (Middle)</sub><br>C/O REDMILE GROUP, LLC<br>ONE LETTERMAN DRIVE, BLDG D SUITE D3-300<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94129<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>FATE THERAPEUTICS INC [ FATE ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-07-02 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 8977624 | D<sup>(1)</sup> |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Pre-Funded Warrants to Purchase Common Stock | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 3691324<sup>(2)</sup> | <sup>(2)</sup> | D<sup>(1)</sup> |  |
| Class A Convertible Preferred Stock | <sup>(3)(5)</sup> | <sup>(5)</sup> | Common Stock | 810065<sup>(4)</sup> | <sup>(5)</sup> | D<sup>(1)</sup> |  |
| Cash-settled Swaps | <sup>(6)(7)(8)</sup> | <sup>(7)</sup> | Common Stock | 266280 | 5.84<sup>(9)</sup> | D<sup>(1)</sup> |  |

---

### Footnotes:

(1) The securities reported herein are directly owned by RedCo II Master Fund, L.P. ("RedCo II"), which is a fund managed by Redmile Group, LLC, and have been included among the securities previously reported in Section 16 filings reporting the indirect beneficial ownership of Redmile Group, LLC and Jeremy C. Green.

(2) The Warrants have no expiration date and are exercisable at any time on or after the original issuance date until fully exercised, at an exercise price equal to $0.001 per share, subject to a beneficial ownership blocker of 9.99%, which percentage may be changed to up to 19.99% at a holder's election upon at least 61 days' notice to the Issuer.  As of July 1, 2025, Redmile Group, LLC ("Redmile") elected to increase the beneficial ownership blocker percentage with respect to the Warrants held by certain private funds managed by Redmile, including RedCo II, to 14.99%, which will be effective within 60 days of the date listed above.

(3) The Class A Preferred Stock is convertible into Common Stock in accordance with the terms of Issuer's Amended and Restated Certificate of Incorporation and the Issuer's Certificate of Designation of Preferences, Rights and Limitations of Class A Convertible Preferred Stock (as amended and restated, the "Certificate of Designation") at any time and from time to time at the holder's election based on a conversion ratio equal to the Class A Preferred Stock's stated value of $13.30 divided by its conversion price of $2.66.

(4) The one-for-five conversion rate is taken into account in the amount of underlying Common Stock listed under Column 3 of Table II.

(5) The Certificate of Designation provides that the holder may not convert any shares of Class A Preferred Stock if, after giving effect to the attempted conversion, the holder and its affiliates would beneficially own in the aggregate more than 14.99% of the number of shares of Common Stock outstanding after giving effect to such attempted conversion, which percentage may be changed at a holder's election upon 61 days' notice to the Issuer. The Class A Preferred Stock has no expiration date and no conversion price.

(6) RedCo II is party to swap agreements with counterparties. Each notional share subject to each swap agreement represents the economic equivalent of one share of the Issuer's common stock. These agreements do not give RedCo II direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparties thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, RedCo II disclaims any beneficial ownership in securities that may be referenced in such swap agreements or that may be held from time to time by any counterparties to the agreements.

(7) RedCo II has the right to terminate and close out each swap at any time.

(8) Upon settlement of the various swap agreements, either (i) the counterparty will pay to RedCo II in cash an amount determined in part by reference to any increase between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement or (ii) RedCo II will pay to the counterparty in cash an amount determined in part by reference to any decrease between the reference price and the market value of the notional number of shares of Common Stock subject to the swap agreement.

(9) Represents the reference price associated with the swap agreements.

**Remarks:**
Mr. Michael Lee, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, RedCo II is a director by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

**Signature:** By: /s/ Jeremy Green, Managing Member of RedCo II (GP), LLC  
**Date:** 2025-07-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**